Jiaoti Huang | Scholars@Duke

Jiaoti Huang
Endowed Department Chair of Pathology

I am a physician-scientist with clinical expertise in the pathologic diagnosis of genitourinary tumors including tumors of the prostate, bladder, kidney and testis. Another area of interest is gynecologic tumors. In my research laboratory we study prostate cancer, focusing on molecular mechanisms of carcinogenesis and tumor progression, as well as biomarkers, imaging and novel therapeutic strategies. In addition to patient care and research, I am also passionate about education. I have trained numerous residents, fellows, graduate students and postdocs.

Current Appointments & Affiliations

Endowed Department Chair of Pathology, Pathology, Clinical Science Departments 2017
Professor of Pathology, Pathology, Clinical Science Departments 2016
Chair, Pathology, Clinical Science Departments 2016
Professor of Pharmacology and Cancer Biology, Pharmacology & Cancer Biology, Basic Science Departments 2017
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2016

Contact Information

Background
Education, Training, & Certifications
- Ph.D., New York University 1991
- M.D., Anhui Medical University (China) 1983
Duke Appointment History
- Instructor, Temporary in the Department of Pathology, Pathology, Clinical Science Departments 2015
Recognition
In the News
- DEC 5, 2019 Duke Health News
  
  Drug Tested in Lab Studies Halts Prostate Cancer Cells That Are Impervious to Hormone Therapy
Research
Selected Grants
- Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer awarded by National Institutes of Health 2019 - 2024
- A novel mitotic regulatory axis in neuroendocrine prostate cancer awarded by University of Pittsburgh 2019 - 2024
- Duke Resident Physician-Scientist Program in Radiation Oncology and Radiology awarded by National Institutes of Health 2020 - 2024
- Targeting neuroendocrine prostate cancer by engineering 3' untranslated regions awarded by Department of Defense 2020 - 2023
- Duke CTSA (TL1) awarded by National Institutes of Health 2018 - 2023
- Targeting Glutaminase Isoforms for Therapy-Resistant Prostate Cancer awarded by Department of Defense 2019 - 2022
- Defining the Essential Determinants of Prostate Cancer Differentiation States awarded by National Institutes of Health 2019 - 2022
- Role of oncogenic phosphorylated MED1 in aggressive prostate cancer awarded by National Institutes of Health 2017 - 2022
- Confirmation of histologic SCNC (NEPC) awarded by BioXcel Therapeutics 2019 - 2022
- Targeting castration-resistant prostate cancer by engineering 3'UTR awarded by Department of Defense 2020 - 2022
- Targeting the p38/Snail/PD-L1 axis in hormone-therapy resistance and metastasis awarded by Department of Defense 2018 - 2021
- Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer awarded by National Institutes of Health 2016 - 2021
- Role and targeting of PRMT5 in prostate cancer awarded by Purdue University 2017 - 2021
- Assessment of macrophage density in historical tNEPC tissue samples. awarded by BioXcel Therapeutics 2019 - 2021
- Unveiling the roles of neuroendocrine cells in prostate cancer development awarded by Mike Slive Foundation 2020
- Targeting RNA splicing in race-related aggressive and lethal prostate cancer awarded by Prostate Cancer Foundation 2018 - 2020
- Identification of DNA methylation markers for risk of metastasis in localized prostate cancer awarded by Kaiser Permanente 2016 - 2020
- Novel Tumor Suppressive Role of Phosphodiesterases in Prostate Cancer awarded by Department of Defense 2016 - 2020
- Systems Analysis of Epigenomic Architecture in Cancer Progression (Project 2: Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function) awarded by University of Texas Health Science Center at San Antonio 2017 - 2020
- Heparan sulfate in prostate cancer awarded by University of South Florida 2019 - 2020
- Targeting Adaptive Pathways in Abiraterone- and Enzalutamide-Refractory Intermediate Atypical Carcinoma awarded by University of California - San Francisco 2016 - 2019
- Role of the Stroma in Fibrolamellar Hepatocellular Carcinoma awarded by Fibrolamellar Cancer Foundation 2016 - 2019
- Genetic screen of calorie restricted and western diet essential kinases in prostate cancer awarded by Prostate Cancer Foundation 2018 - 2019
- Heparan sulfate in prostate cancer awarded by University of Georgia 2018
- Paired Acquisition In Refractory Prostate Cancer (PAIR): Advancing the Promise of the PCF/SU2C/AACR West Coast Prostate Cancer Dream Team awarded by University of California - San Francisco 2016 - 2018
- A novel strategy to identify prostate cancer biomarkers for patient management awarded by National Institutes of Health 2013 - 2018
- Systems Analysis of Epigenomic Architecture in Cancer Progression awarded by University of Texas Health Science Center at San Antonio 2017 - 2018
- : Identification of DNA methylation markers for risk of metastasis in localized prostate cancer awarded by Kaiser Permanente 2016
- Stand Up 2 Cancer West Coast Dream Team Grant awarded by University of San Francisco 2013 - 2016
External Relationships
- Gem Flower Healthcare
- Gencode
- Genetron Health
- Jing-Meng Stem Cell
- Kingmed Diagnostics
- MoreHealth
- Omnitura Therapeutics
- OptraScan
- SISU Pharma
- VetoncoRx
- York Biotechnology
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Morris, D Cody, Derek Y. Chan, Theresa H. Lye, Hong Chen, Mark L. Palmeri, Thomas J. Polascik, Wen-Chi Foo, Jiaoti Huang, Jonathan Mamou, and Kathryn R. Nightingale. “Multiparametric Ultrasound for Targeting Prostate Cancer: Combining ARFI, SWEI, QUS and B-Mode.” Ultrasound Med Biol 46, no. 12 (December 2020): 3426–39. https://doi.org/10.1016/j.ultrasmedbio.2020.08.022.
    Full Text Link to Item
  - Beketova, Elena, Shuyi Fang, Jake L. Owens, Sheng Liu, Xufeng Chen, Qingfu Zhang, Andrew M. Asberry, et al. “Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer.” Cancer Res 80, no. 22 (November 15, 2020): 4904–17. https://doi.org/10.1158/0008-5472.CAN-20-1228.
    Full Text Link to Item
  - Lin, Shian-Ren, Yu-Ching Wen, Hsiu-Lien Yeh, Kuo-Ching Jiang, Wei-Hao Chen, Ntlotlang Mokgautsi, Jiaoti Huang, Wei-Yu Chen, and Yen-Nien Liu. “EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.” Oncogene 39, no. 44 (October 2020): 6757–75. https://doi.org/10.1038/s41388-020-01468-9.
    Full Text Link to Item
  - Lovnicki, Jessica, Yu Gan, Tingting Feng, Yinan Li, Ning Xie, Chia-Hao Ho, Ahn R. Lee, et al. “LIN28B promotes the development of neuroendocrine prostate cancer.” J Clin Invest 130, no. 10 (October 1, 2020): 5338–48. https://doi.org/10.1172/JCI135373.
    Full Text Link to Item
  - Fine, Samson W., Kiril Trpkov, Mahul B. Amin, Ferran Algaba, Manju Aron, Dilek E. Baydar, Antonio Lopez Beltran, et al. “Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.” Urol Oncol, September 15, 2020. https://doi.org/10.1016/j.urolonc.2020.08.027.
    Full Text Link to Item
  - Guan, Xiangnan, Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert Evan Reiter, Matthew Rettig, Christopher P. Evans, et al. “Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer.” Clin Cancer Res 26, no. 17 (September 1, 2020): 4616–24. https://doi.org/10.1158/1078-0432.CCR-19-2303.
    Full Text Link to Item
  - Hankey, William, Benjamin Sunkel, Fuwen Yuan, Haiyan He, Jennifer M. Thomas-Ahner, Zhong Chen, Steven K. Clinton, Jiaoti Huang, and Qianben Wang. “Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range.” Transl Oncol 13, no. 9 (September 2020): 100797. https://doi.org/10.1016/j.tranon.2020.100797.
    Full Text Link to Item
  - Kahokehr, A Adam, William R. Boysen, Michael H. Schild, Brent D. Nosé, Jiaoti Huang, Will Eward, and Andrew C. Peterson. “Urinary pubic symphysis fistula leads to histopathologic osteomyelitis in prostate cancer survivors.” Urology, August 4, 2020. https://doi.org/10.1016/j.urology.2020.07.038.
    Full Text Open Access Copy Link to Item
  - Zhao, Shuang G., William S. Chen, Haolong Li, Adam Foye, Meng Zhang, Martin Sjöström, Rahul Aggarwal, et al. “The DNA methylation landscape of advanced prostate cancer.” Nat Genet 52, no. 8 (August 2020): 778–89. https://doi.org/10.1038/s41588-020-0648-8.
    Full Text Link to Item
  - Kwon, Daniel H., Li Zhang, David A. Quigley, Adam Foye, William S. Chen, Christopher K. Wong, Felix Y. Feng, et al. “Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer.” Urol Oncol, July 2, 2020. https://doi.org/10.1016/j.urolonc.2020.06.002.
    Full Text Link to Item
  - Wang, Jun, Chaoyi Yu, Shuaibin Zhang, Juanying Ye, Hang Dai, Hongkuan Wang, Jiyue Huang, et al. “Cell-type-dependent histone demethylase specificity promotes meiotic chromosome condensation in Arabidopsis.” Nat Plants 6, no. 7 (July 2020): 823–37. https://doi.org/10.1038/s41477-020-0697-0.
    Full Text Link to Item
  - Li, Qiuhui, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, et al. “Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.” Nat Commun 11, no. 1 (June 4, 2020): 2895. https://doi.org/10.1038/s41467-020-16615-9.
    Full Text Link to Item
  - Alumkal, Joshi J., Duanchen Sun, Eric Lu, Tomasz M. Beer, George V. Thomas, Emile Latour, Rahul Aggarwal, et al. “Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.” Proc Natl Acad Sci U S A 117, no. 22 (June 2, 2020): 12315–23. https://doi.org/10.1073/pnas.1922207117.
    Full Text Link to Item
  - Aggarwal, Rahul, Gustavo Rubio Romero, Verena Friedl, Alana Weinstein, Adam Foye, Jiaoti Huang, Felix Feng, Joshua M. Stuart, and Eric J. Small. “Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer.” Prostate Cancer and Prostatic Diseases, April 14, 2020. https://doi.org/10.1038/s41391-020-0228-0.
    Full Text
  - Brown, Landon C., Jason Zhu, Matthew K. Labriola, Yuan Wu, Sachica Cheris, Xin Liu, Kathryn Perkinson, et al. “PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma.” Clin Genitourin Cancer, April 10, 2020. https://doi.org/10.1016/j.clgc.2020.03.020.
    Full Text Link to Item
  - Gan, Yu, Yinan Li, Zhi Long, Ahn R. Lee, Ning Xie, Jessica M. Lovnicki, Yuxin Tang, Xiang Chen, Jiaoti Huang, and Xuesen Dong. “Corrigendum to 'Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer'. [EBioMedicine 31 (2018) 267-275>.” Ebiomedicine 54 (April 2020): 102741. https://doi.org/10.1016/j.ebiom.2020.102741.
    Full Text Link to Item
  - Zhou, Steve R., Edward Chang, Aalhad Patankar, Jiaoti Huang, Leonard S. Marks, and Shyam Natarajan. “Prostate Cancer Detection Rate of Freehand versus 3-Dimensional Template Mapping Biopsy Using a Magnetic Resonance Imaging-Ultrasound Fusion Device in Biopsy Naïve Men.” J Urol 203, no. 4 (April 2020): 699–705. https://doi.org/10.1097/JU.0000000000000587.
    Full Text Link to Item
  - Hu, Jing, Bo Han, and Jiaoti Huang. “Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.” Archives of Pathology & Laboratory Medicine 144, no. 3 (March 2020): 320–25. https://doi.org/10.5858/arpa.2019-0434-ra.
    Full Text
  - Huang, Jiaoti, and Lanjing Zhang. “Frontiers in Genitourinary Pathology.” Arch Pathol Lab Med 144, no. 3 (March 2020): 275–76. https://doi.org/10.5858/arpa.2019-0560-ED.
    Full Text Link to Item
  - Zhang, Yaqun, Lingfan Xu, Yan Chang, YanJing Li, William Butler, Er Jin, Aifen Wang, et al. “Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC.” Prostate Cancer Prostatic Dis 23, no. 1 (March 2020): 160–71. https://doi.org/10.1038/s41391-019-0172-z.
    Full Text Open Access Copy Link to Item
  - Owens, Jake L., Elena Beketova, Sheng Liu, Samantha L. Tinsley, Andrew M. Asberry, Xuehong Deng, Jiaoti Huang, Chenglong Li, Jun Wan, and Chang-Deng Hu. “PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes.” Iscience 23, no. 1 (January 24, 2020): 100750. https://doi.org/10.1016/j.isci.2019.100750.
    Full Text Link to Item
  - Wang, Liang, Bryan A. Smith, Nikolas G. Balanis, Brandon L. Tsai, Kim Nguyen, Michael W. Cheng, Matthew B. Obusan, et al. “A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.” Proc Natl Acad Sci U S A 117, no. 1 (January 7, 2020): 563–72. https://doi.org/10.1073/pnas.1915770117.
    Full Text Link to Item
  - Li, Yanjing, Yiping He, William Butler, Lingfan Xu, Yan Chang, Kefeng Lei, Hong Zhang, et al. “Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.” Sci Transl Med 11, no. 521 (December 4, 2019). https://doi.org/10.1126/scitranslmed.aax0428.
    Full Text Link to Item
  - Li, Qiuhui, Bigang Liu, Hsueh-Ping Chao, Yibing Ji, Yue Lu, Rashid Mehmood, Collene Jeter, et al. “LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.” Nat Commun 10, no. 1 (December 2, 2019): 5494. https://doi.org/10.1038/s41467-019-13532-4.
    Full Text Link to Item
  - Nickols, Nicholas G., Ramin Nazarian, Shuang G. Zhao, Victor Tan, Vladislav Uzunangelov, Zheng Xia, Robert Baertsch, et al. “MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer.” Prostate Cancer Prostatic Dis 22, no. 4 (December 2019): 531–38. https://doi.org/10.1038/s41391-019-0134-5.
    Full Text Link to Item
  - Okhunov, Zhamshid, RongWei Mao, Francis A. Jefferson, Renai Yoon, Roshan M. Patel, Thomas K. Lee, Jiaoti Huang, et al. “Initial Evaluation of a Novel Modulated Radiofrequency-based Bladder Denervation Device.” Urology 134 (December 2019): 237–42. https://doi.org/10.1016/j.urology.2019.08.046.
    Full Text Link to Item
  - Yuan, Fuwen, William Hankey, Dayong Wu, Hongyan Wang, Jason Somarelli, Andrew J. Armstrong, Jiaoti Huang, Zhong Chen, and Qianben Wang. “Molecular determinants for enzalutamide-induced transcription in prostate cancer.” Nucleic Acids Res 47, no. 19 (November 4, 2019): 10104–14. https://doi.org/10.1093/nar/gkz790.
    Full Text Open Access Copy Link to Item
  - Chen, William S., Rahul Aggarwal, Li Zhang, Shuang G. Zhao, George V. Thomas, Tomasz M. Beer, David A. Quigley, et al. “Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer.” Eur Urol 76, no. 5 (November 2019): 562–71. https://doi.org/10.1016/j.eururo.2019.03.020.
    Full Text Link to Item
  - An, Qin, Youjin Hu, Qingjiao Li, Xufeng Chen, Jiaoti Huang, Matteo Pellegrini, Xianghong Jasmine Zhou, Matthew Rettig, and Guoping Fan. “The size of cell-free mitochondrial DNA in blood is inversely correlated with tumor burden in cancer patients.” Precision Clinical Medicine 2, no. 3 (September 2019): 131–39. https://doi.org/10.1093/pcmedi/pbz014.
    Full Text
  - Chen, Ming, and Jiaoti Huang. “The expanded role of fatty acid metabolism in cancer: new aspects and targets.” Precision Clinical Medicine 2, no. 3 (September 2019): 183–91. https://doi.org/10.1093/pcmedi/pbz017.
    Full Text Open Access Copy
  - Li, Yinan, Ning Xie, Ruiqi Chen, Ahn R. Lee, Jessica Lovnicki, Emma A. Morrison, Ladan Fazli, et al. “RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.” Eur Urol 76, no. 2 (August 2019): 157–66. https://doi.org/10.1016/j.eururo.2019.03.011.
    Full Text Link to Item
  - Balanis, Nikolas G., Katherine M. Sheu, Favour N. Esedebe, Saahil J. Patel, Bryan A. Smith, Jung Wook Park, Salwan Alhani, et al. “Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.” Cancer Cell 36, no. 1 (July 8, 2019): 17-34.e7. https://doi.org/10.1016/j.ccell.2019.06.005.
    Full Text Link to Item
  - Liu, Yen-Nien, Shaoxi Niu, Wei-Yu Chen, Qingfu Zhang, Yulei Tao, Wei-Hao Chen, Kuo-Ching Jiang, et al. “Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.” Clin Cancer Res 25, no. 13 (July 1, 2019): 4128–40. https://doi.org/10.1158/1078-0432.CCR-18-3239.
    Full Text Link to Item
  - Yin, Yu, Lingfan Xu, Yan Chang, Tao Zeng, Xufeng Chen, Aifen Wang, Jeff Groth, et al. “Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway.” Mol Cancer 18, no. 1 (June 19, 2019): 107. https://doi.org/10.1186/s12943-019-1034-y.
    Full Text Link to Item
  - Ma, Xin, and Jiaoti Huang. “Predicting clinical outcome of therapy-resistant prostate cancer.” Proc Natl Acad Sci U S A 116, no. 23 (June 4, 2019): 11090–92. https://doi.org/10.1073/pnas.1906812116.
    Full Text Link to Item
  - Aggarwal, Rahul R., David A. Quigley, Jiaoti Huang, Li Zhang, Tomasz M. Beer, Matthew B. Rettig, Rob E. Reiter, et al. “Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.” Mol Cancer Res 17, no. 6 (June 2019): 1235–40. https://doi.org/10.1158/1541-7786.MCR-18-1101.
    Full Text Link to Item
  - Feng, Ninghan, and Jiaoti Huang. “Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression.” Asian J Androl 21, no. 3 (May 2019): 213–14. https://doi.org/10.4103/aja.aja_31_19.
    Full Text Link to Item
  - Huang, Yu-Hua, Ya-Qun Zhang, and Jiao-Ti Huang. “Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms.” Asian J Androl 21, no. 3 (May 2019): 291–95. https://doi.org/10.4103/aja.aja_128_18.
    Full Text Link to Item
  - Xu, Yadong, Qiong Song, Laura E. Pascal, Mingming Zhong, Yibin Zhou, Jianhua Zhou, Fang-Ming Deng, Jiaoti Huang, and Zhou Wang. “DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.” Prostate 79, no. 6 (May 2019): 657–66. https://doi.org/10.1002/pros.23773.
    Full Text Link to Item
  - Taylor, Clive R., Anagha P. Jadhav, Abhi Gholap, Gurunath Kamble, Jiaoti Huang, Allen Gown, Isha Doshi, and David L. Rimm. “A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed Death-Ligand 1 (PD-L1) Expression in Non-Small Cell Lung Cancer.” Appl Immunohistochem Mol Morphol 27, no. 4 (April 2019): 263–69. https://doi.org/10.1097/PAI.0000000000000737.
    Full Text Link to Item
  - Zhang, Jinfang, Ming Chen, Yasheng Zhu, Xiangpeng Dai, Fabin Dang, Junming Ren, Shancheng Ren, et al. “SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.” Dev Cell 48, no. 3 (February 11, 2019): 329-344.e5. https://doi.org/10.1016/j.devcel.2018.11.035.
    Full Text Open Access Copy Link to Item
  - Aggarwal, Rahul, Jiaoti Huang, Joshi Alumkal, Felix Y. Feng, Li Zhang, Joshua M. Stuart, and Eric J. Small. “Reply to A. Dalla Volta et al.” J Clin Oncol 37, no. 4 (February 1, 2019): 351–52. https://doi.org/10.1200/JCO.18.01487.
    Full Text Link to Item
  - Yin, Yu, Lingfan Xu, Yan Chang, Tao Zeng, Xufeng Chen, Aifeng Wang, Jeff Groth, et al. “N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.” Molecular Cancer 18, no. 1 (January 18, 2019): 11. https://doi.org/10.1186/s12943-019-0941-2.
    Full Text
  - Koo, Matthew, Jill M. Squires, Daphne Ying, and Jiaoti Huang. “Making a Tissue Microarray.” Methods Mol Biol 1897 (2019): 313–23. https://doi.org/10.1007/978-1-4939-8935-5_27.
    Full Text Link to Item
  - Li, Yinan, Qingfu Zhang, Jessica Lovnicki, Ruiqi Chen, Ladan Fazli, Yuzhuo Wang, Martin Gleave, Jiaoti Huang, and Xuesen Dong. “SRRM4 gene expression correlates with neuroendocrine prostate cancer.” Prostate 79, no. 1 (January 2019): 96–104. https://doi.org/10.1002/pros.23715.
    Full Text Link to Item
  - Xu, Lingfan, Enze Ma, Tao Zeng, Ruya Zhao, Yulei Tao, Xufeng Chen, Jeff Groth, Chaozhao Liang, Hailiang Hu, and Jiaoti Huang. “ATM deficiency promotes progression of CRPC by enhancing Warburg effect.” Endocr Relat Cancer 26, no. 1 (January 1, 2019): 59–71. https://doi.org/10.1530/ERC-18-0196.
    Full Text Link to Item
  - Xu, Lingfan, Junyi Chen, Weipeng Liu, Chaozhao Liang, Hailiang Hu, and Jiaoti Huang. “Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer.” Asian J Urol 6, no. 1 (January 2019): 91–98. https://doi.org/10.1016/j.ajur.2018.11.002.
    Full Text Open Access Copy Link to Item
  - Zhang, Tian, Andrew J. Armstrong, Daniel J. George, and Jiaoti Huang. “The promise of immunotherapy in genitourinary malignancies.” Precis Clin Med 1, no. 3 (December 2018): 97–101. https://doi.org/10.1093/pcmedi/pby018.
    Full Text Link to Item
  - Aminsharifi, Alireza, Rajan T. Gupta, Jiaoti Huang, and Thomas J. Polascik. “Three-dimensional localization and targeting of prostate cancer foci with imaging and histopathologic correlation: establishing a multidisciplinary team for quality improvement.” Curr Opin Urol 28, no. 6 (November 2018): 506–11. https://doi.org/10.1097/MOU.0000000000000554.
    Full Text Link to Item
  - Quigley, David A., Ha X. Dang, Shuang G. Zhao, Paul Lloyd, Rahul Aggarwal, Joshi J. Alumkal, Adam Foye, et al. “Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.” Cell 175, no. 3 (October 18, 2018): 889. https://doi.org/10.1016/j.cell.2018.10.019.
    Full Text Link to Item
  - Park, Jung Wook, John K. Lee, Katherine M. Sheu, Liang Wang, Nikolas G. Balanis, Kim Nguyen, Bryan A. Smith, et al. “Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage.” Science 362, no. 6410 (October 5, 2018): 91–95. https://doi.org/10.1126/science.aat5749.
    Full Text Link to Item
  - Smith, Bryan A., Nikolas G. Balanis, Avinash Nanjundiah, Katherine M. Sheu, Brandon L. Tsai, Qingfu Zhang, Jung Wook Park, et al. “A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers.” Cell Rep 24, no. 12 (September 18, 2018): 3353-3366.e5. https://doi.org/10.1016/j.celrep.2018.08.062.
    Full Text Link to Item
  - Li, Qiuhui, Qu Deng, Hsueh-Ping Chao, Xin Liu, Yue Lu, Kevin Lin, Bigang Liu, et al. “Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.” Nat Commun 9, no. 1 (September 6, 2018): 3600. https://doi.org/10.1038/s41467-018-06067-7.
    Full Text Link to Item
  - Nagarajan, Mahesh B., Steven S. Raman, Pechin Lo, Wei-Chan Lin, Pooria Khoshnoodi, James W. Sayre, Bharath Ramakrishna, et al. “Building a high-resolution T2-weighted MR-based probabilistic model of tumor occurrence in the prostate.” Abdom Radiol (Ny) 43, no. 9 (September 2018): 2487–96. https://doi.org/10.1007/s00261-018-1495-2.
    Full Text Link to Item
  - Lei, Kefeng, Ran Sun, Lee H. Chen, Bill H. Diplas, Casey J. Moure, Wenzhe Wang, Landon J. Hansen, et al. “Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells.” Sci Rep 8, no. 1 (August 21, 2018): 12507. https://doi.org/10.1038/s41598-018-30062-z.
    Full Text Link to Item
  - Aggarwal, Rahul, Jiaoti Huang, Joshi J. Alumkal, Li Zhang, Felix Y. Feng, George V. Thomas, Alana S. Weinstein, et al. “Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study.” J Clin Oncol 36, no. 24 (August 20, 2018): 2492–2503. https://doi.org/10.1200/JCO.2017.77.6880.
    Full Text Link to Item
  - Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.” Urol Clin North Am 45, no. 3 (August 2018): 455–66. https://doi.org/10.1016/j.ucl.2018.03.010.
    Full Text Link to Item
  - Quigley, David A., Ha X. Dang, Shuang G. Zhao, Paul Lloyd, Rahul Aggarwal, Joshi J. Alumkal, Adam Foye, et al. “Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.” Cell 174, no. 3 (July 26, 2018): 758-769.e9. https://doi.org/10.1016/j.cell.2018.06.039.
    Full Text Link to Item
  - Alle, Nisha, Nelly Tan, Julie Huss, Jiatoi Huang, Allan Pantuck, and Steven S. Raman. “Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.” Abdom Radiol (Ny) 43, no. 7 (July 2018): 1813–19. https://doi.org/10.1007/s00261-017-1337-7.
    Full Text Link to Item
  - Chen, Zhong, Dayong Wu, Jennifer M. Thomas-Ahner, Changxue Lu, Pei Zhao, Qingfu Zhang, Connor Geraghty, et al. “Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.” Proc Natl Acad Sci U S A 115, no. 26 (June 26, 2018): 6810–15. https://doi.org/10.1073/pnas.1718811115.
    Full Text Link to Item
  - Gan, Yu, Yinan Li, Zhi Long, Ahn R. Lee, Ning Xie, Jessica M. Lovnicki, Yuxin Tang, Xiang Chen, Jiaoti Huang, and Xuesen Dong. “Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.” Ebiomedicine 31 (May 2018): 267–75. https://doi.org/10.1016/j.ebiom.2018.05.002.
    Full Text Link to Item
  - Lee, John K., Nathanael J. Bangayan, Timothy Chai, Bryan A. Smith, Tiffany E. Pariva, Sangwon Yun, Ajay Vashisht, et al. “Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.” Proceedings of the National Academy of Sciences of the United States of America 115, no. 19 (May 2018): E4473–82. https://doi.org/10.1073/pnas.1802354115.
    Full Text
  - Okhunov, Zhamshid, Renai Yoon, Achim Lusch, Kyle Spradling, Melissa Suarez, Kamaljot S. Kaler, Roshan Patel, et al. “Evaluation and Comparison of Contemporary Energy-Based Surgical Vessel Sealing Devices.” J Endourol 32, no. 4 (April 2018): 329–37. https://doi.org/10.1089/end.2017.0596.
    Full Text Link to Item
  - Duvnjak, Petar, Ariel A. Schulman, Jamie N. Holtz, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “Multiparametric Prostate MR Imaging: Impact on Clinical Staging and Decision Making.” Radiol Clin North Am 56, no. 2 (March 2018): 239–50. https://doi.org/10.1016/j.rcl.2017.10.007.
    Full Text Link to Item
  - Holtz, Jamie N., Rachel Kloss Silverman, Kae Jack Tay, Jill T. Browning, Jiaoti Huang, Thomas J. Polascik, and Rajan T. Gupta. “New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?” Abdom Radiol (Ny) 43, no. 3 (March 2018): 702–12. https://doi.org/10.1007/s00261-017-1255-8.
    Full Text Link to Item
  - Nassiri, Nima, Edward Chang, Patricia Lieu, Alan M. Priester, Daniel J. A. Margolis, Jiaoti Huang, Robert E. Reiter, Frederick J. Dorey, Leonard S. Marks, and Shyam Natarajan. “Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.” J Urol 199, no. 2 (February 2018): 453–58. https://doi.org/10.1016/j.juro.2017.08.085.
    Full Text Link to Item
  - Chang, Edward, Tonye A. Jones, Shyam Natarajan, Devi Sharma, Demetrios Simopoulos, Daniel J. Margolis, Jiaoti Huang, Frederick J. Dorey, and Leonard S. Marks. “Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.” J Urol 199, no. 1 (January 2018): 98–105. https://doi.org/10.1016/j.juro.2017.07.038.
    Full Text Link to Item
  - Felker, Ely R., Steven S. Raman, Daniel J. Margolis, David S. K. Lu, Nicholas Shaheen, Shyam Natarajan, Devi Sharma, Jiaoti Huang, Fred Dorey, and Leonard S. Marks. “Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?” Ajr Am J Roentgenol 209, no. 6 (December 2017): 1272–77. https://doi.org/10.2214/AJR.17.18008.
    Full Text Link to Item
  - Chen, W. -. Y., Y. -. C. Tsai, M. K. Siu, H. -. L. Yeh, C. -. L. Chen, J. J. Yin, J. Huang, and Y. -. N. Liu. “Inhibition of the androgen receptor induces a novel tumor promoter, ZBTB46, for prostate cancer metastasis.” Oncogene 36, no. 45 (November 9, 2017): 6213–24. https://doi.org/10.1038/onc.2017.226.
    Full Text Link to Item
  - Aggarwal, Rahul, Spencer C. Behr, Pamela L. Paris, Charles Truillet, Matthew F. L. Parker, Loc T. Huynh, Junnian Wei, et al. “Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.” Mol Cancer Res 15, no. 9 (September 2017): 1221–29. https://doi.org/10.1158/1541-7786.MCR-17-0196.
    Full Text Link to Item
  - Dai, Xiangpeng, Wenjian Gan, Xiaoning Li, Shangqian Wang, Wei Zhang, Ling Huang, Shengwu Liu, et al. “Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.” Nature Medicine 23, no. 9 (September 2017): 1063–71. https://doi.org/10.1038/nm.4378.
    Full Text
  - Park, Jung Wook, John K. Lee, Owen N. Witte, and Jiaoti Huang. “FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.” Mod Pathol 30, no. 9 (September 2017): 1262–72. https://doi.org/10.1038/modpathol.2017.44.
    Full Text Link to Item
  - Tay, K. J., M. J. Scheltema, H. U. Ahmed, E. Barret, J. A. Coleman, J. Dominguez-Escrig, S. Ghai, et al. “Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.” Prostate Cancer and Prostatic Diseases 20, no. 3 (September 2017): 294–99. https://doi.org/10.1038/pcan.2017.8.
    Full Text
  - Chen, Wei-Yu, Yuan-Chin Tsai, Hsiu-Lien Yeh, Florent Suau, Kuo-Ching Jiang, Ai-Ning Shao, Jiaoti Huang, and Yen-Nien Liu. “Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.” Science Signaling 10, no. 492 (August 15, 2017). https://doi.org/10.1126/scisignal.aam6826.
    Full Text
  - Holmes, Michael G., Erik Foss, Gabby Joseph, Adam Foye, Brooke Beckett, Daria Motamedi, Jack Youngren, et al. “CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.” Journal of Vascular and Interventional Radiology : Jvir 28, no. 8 (August 2017): 1073-1081.e1. https://doi.org/10.1016/j.jvir.2017.04.019.
    Full Text
  - Grant, Delores J., Zinan Chen, Lauren E. Howard, Emily Wiggins, Amanda De Hoedt, Adriana C. Vidal, Skyla T. Carney, et al. “UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.” Bmc Cancer 17, no. 1 (July 3, 2017): 463. https://doi.org/10.1186/s12885-017-3463-6.
    Full Text Link to Item
  - Chen, Ke, Haibing Xiao, Jin Zeng, Gan Yu, Hui Zhou, Chunhua Huang, Weimin Yao, et al. “Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.” Clin Cancer Res 23, no. 13 (July 1, 2017): 3428–41. https://doi.org/10.1158/1078-0432.CCR-16-2020.
    Full Text Link to Item
  - Jamshidi, Neema, Daniel J. Margolis, Steven Raman, Jiaoti Huang, Robert E. Reiter, and Michael D. Kuo. “Multiregional Radiogenomic Assessment of Prostate Microenvironments with Multiparametric MR Imaging and DNA Whole-Exome Sequencing of Prostate Glands with Adenocarcinoma.” Radiology 284, no. 1 (July 2017): 109–19. https://doi.org/10.1148/radiol.2017162827.
    Full Text
  - Hegde, J. V., D. J. Margolis, P. -. C. Wang, R. E. Reiter, J. Huang, M. L. Steinberg, and M. Kamrava. “Establishing the distribution of satellite lesions in intermediate- and high-risk prostate cancer: implications for focused radiotherapy.” Prostate Cancer Prostatic Dis 20, no. 2 (June 2017): 241–48. https://doi.org/10.1038/pcan.2016.75.
    Full Text Link to Item
  - Nassiri, Nima, Daniel J. Margolis, Shyam Natarajan, Devi S. Sharma, Jiaoti Huang, Frederick J. Dorey, and Leonard S. Marks. “Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.” The Journal of Urology 197, no. 3 Pt 1 (March 2017): 632–39. https://doi.org/10.1016/j.juro.2016.09.070.
    Full Text
  - Palapattu, Ganesh S., Simpa S. Salami, Andi K. Cani, Daniel H. Hovelson, Lorena Lazo de la Vega, Kelly R. Vandenberg, Jarred V. Bratley, et al. “Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.” Clin Cancer Res 23, no. 4 (February 15, 2017): 985–91. https://doi.org/10.1158/1078-0432.CCR-16-1454.
    Full Text Link to Item
  - Priester, Alan, Shyam Natarajan, Pooria Khoshnoodi, Daniel J. Margolis, Steven S. Raman, Robert E. Reiter, Jiaoti Huang, Warren Grundfest, and Leonard S. Marks. “Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.” J Urol 197, no. 2 (February 2017): 320–26. https://doi.org/10.1016/j.juro.2016.07.084.
    Full Text Link to Item
  - Feng, Ninghan, Yu Yin, Yiping He, and Jiaoti Huang. “Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma.” Eur Urol 71, no. 1 (January 2017): 79–80. https://doi.org/10.1016/j.eururo.2016.07.046.
    Full Text Link to Item
  - Tsai, Yuan-Chin, Wei-Yu Chen, Man Kit Siu, Hong-Yuan Tsai, Juan Juan Yin, Jiaoti Huang, and Yen-Nien Liu. “Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.” Cancer Lett 384 (January 1, 2017): 1–8. https://doi.org/10.1016/j.canlet.2016.10.014.
    Full Text Link to Item
  - Yin, Yu, Qingfu Zhang, Hong Zhang, Yiping He, and Jiaoti Huang. “Molecular Signature to Risk-Stratify Prostate Cancer of Intermediate Risk.” Clin Cancer Res 23, no. 1 (January 1, 2017): 6–8. https://doi.org/10.1158/1078-0432.CCR-16-2400.
    Full Text Open Access Copy Link to Item
  - Wu, Meng, Lishann Ingram, Ezequiel J. Tolosa, Renzo E. Vera, Qianjin Li, Sungjin Kim, Yongjie Ma, et al. “Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis.” J Biol Chem 291, no. 49 (December 2, 2016): 25749–60. https://doi.org/10.1074/jbc.M116.753129.
    Full Text Link to Item
  - Aggarwal, Rahul, Tomasz M. Beer, Martin Gleave, Joshua M. Stuart, Matthew Rettig, Christopher P. Evans, Jack Youngren, et al. “Targeting Adaptive Pathways in Metastatic Treatment-Resistant Prostate Cancer: Update on the Stand Up 2 Cancer/Prostate Cancer Foundation-Supported West Coast Prostate Cancer Dream Team.” Eur Urol Focus 2, no. 5 (December 2016): 469–71. https://doi.org/10.1016/j.euf.2016.10.011.
    Full Text Link to Item
  - Yan, Yunwen, Zhen Li, Xiang Xu, Clark Chen, Wei Wei, Ming Fan, Xufeng Chen, Jian Jian Li, Yuan Wang, and Jiaoti Huang. “All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.” Bmc Complementary and Alternative Medicine 16, no. 1 (December 2016). https://doi.org/10.1186/s12906-016-1088-y.
    Full Text
  - Stoyanova, Tanya, Mireille Riedinger, Shu Lin, Claire M. Faltermeier, Bryan A. Smith, Kelvin X. Zhang, Catherine C. Going, et al. “Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.” Proc Natl Acad Sci U S A 113, no. 42 (October 18, 2016): E6457–66. https://doi.org/10.1073/pnas.1614529113.
    Full Text Link to Item
  - Drake, Justin M., Evan O. Paull, Nicholas A. Graham, John K. Lee, Bryan A. Smith, Bjoern Titz, Tanya Stoyanova, et al. “Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer.” Cell 166, no. 4 (August 11, 2016): 1041–54. https://doi.org/10.1016/j.cell.2016.07.007.
    Full Text Link to Item
  - Natarajan, Shyam, Steven Raman, Alan M. Priester, James Garritano, Daniel J. A. Margolis, Patricia Lieu, Maria L. Macairan, Jiaoti Huang, Warren Grundfest, and Leonard S. Marks. “Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.” J Urol 196, no. 1 (July 2016): 68–75. https://doi.org/10.1016/j.juro.2015.12.083.
    Full Text Link to Item
  - Zhang, H., K. Prado, K. X. Zhang, E. M. Peek, J. Lee, X. Wang, J. Huang, G. Li, M. Pellegrini, and A. I. Chin. “Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance.” Clinical Cancer Research, May 17, 2016.
    Link to Item
  - Felker, Ely R., Stephanie A. Lee-Felker, John Feller, Daniel J. Margolis, David S. Lu, Robert Princenthal, Stuart May, et al. “In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer.” Abdominal Radiology 41, no. 5 (May 2016): 954–62. https://doi.org/10.1007/s00261-016-0750-7.
    Full Text
  - Park, J. W., J. K. Lee, J. W. Phillips, P. Huang, D. Cheng, J. Huang, and O. N. Witte. “Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.” Proceedings of the National Academy of Sciences of Usa 113, no. 16 (April 19, 2016): 4482–87.
    Link to Item
  - Park, Jung Wook, John K. Lee, John W. Phillips, Patrick Huang, Donghui Cheng, Jiaoti Huang, and Owen N. Witte. “Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.” Proc Natl Acad Sci U S A 113, no. 16 (April 19, 2016): 4482–87. https://doi.org/10.1073/pnas.1603645113.
    Full Text Link to Item
  - Lee, John K., John W. Phillips, Bryan A. Smith, Jung Wook Park, Tanya Stoyanova, Erin F. McCaffrey, Robert Baertsch, et al. “N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.” Cancer Cell 29, no. 4 (April 11, 2016): 536–47. https://doi.org/10.1016/j.ccell.2016.03.001.
    Full Text Link to Item
  - Li, Wei, Alexa Cohen, Yin Sun, Jill Squires, Daniel Braas, Thomas G. Graeber, Lin Du, et al. “The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.” Molecular Cancer Research : Mcr 14, no. 4 (April 2016): 344–53. https://doi.org/10.1158/1541-7786.mcr-15-0466.
    Full Text
  - Filson, Christopher P., Shyam Natarajan, Daniel J. A. Margolis, Jiaoti Huang, Patricia Lieu, Frederick J. Dorey, Robert E. Reiter, and Leonard S. Marks. “Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.” Cancer 122, no. 6 (March 15, 2016): 884–92. https://doi.org/10.1002/cncr.29874.
    Full Text
  - Faltermeier, Claire M., Justin M. Drake, Peter M. Clark, Bryan A. Smith, Yang Zong, Carmen Volpe, Colleen Mathis, et al. “Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.” Proceedings of the National Academy of Sciences 113, no. 2 (January 12, 2016): E172–81. https://doi.org/10.1073/pnas.1521674112.
    Full Text
  - Chen, Zhong, Xun Lan, Dayong Wu, Benjamin Sunkel, Zhenqing Ye, Jiaoti Huang, Zhihua Liu, Steven K. Clinton, Victor X. Jin, and Qianben Wang. “Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.” Nature Communications 6, no. 1 (November 2015). https://doi.org/10.1038/ncomms9323.
    Full Text
  - Kamrava, Mitchell, Amar U. Kishan, Daniel J. Margolis, Jiaoti Huang, Fred Dorey, Patricia Lieu, Patrick A. Kupelian, and Leonard S. Marks. “Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancer.” Practical Radiation Oncology 5, no. 6 (November 2015): 411–16. https://doi.org/10.1016/j.prro.2015.04.006.
    Full Text
  - Rakow-Penner, Rebecca A., Nathan S. White, Daniel J. A. Margolis, John Kellogg Parsons, Natalie Schenker-Ahmed, Joshua M. Kuperman, Hauke Bartsch, et al. “Prostate diffusion imaging with distortion correction.” Magnetic Resonance Imaging 33, no. 9 (November 2015): 1178–81. https://doi.org/10.1016/j.mri.2015.07.006.
    Full Text
  - Wang, Denong, Xiaohe Liu, Ben Hsieh, Richard Bruce, George Somlo, Jiaoti Huang, and Lidia Sambucetti. “Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.” Archives of Medical Research 46, no. 8 (November 2015): 642–50. https://doi.org/10.1016/j.arcmed.2015.11.007.
    Full Text
  - Chen, Jie-Fu, Hao Ho, Jake Lichterman, Yi-Tsung Lu, Yang Zhang, Mitch A. Garcia, Shang-Fu Chen, et al. “Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.” Cancer 121, no. 18 (September 15, 2015): 3240–51. https://doi.org/10.1002/cncr.29455.
    Full Text
  - Liu, Xin, Xin Chen, Kiera Rycaj, Hsueh-Ping Chao, Qu Deng, Collene Jeter, Can Liu, et al. “Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.” Oncotarget 6, no. 27 (September 15, 2015): 23959–86. https://doi.org/10.18632/oncotarget.4260.
    Full Text
  - Gan, Wenjian, Xiangpeng Dai, Andrea Lunardi, Zhen Li, Hiroyuki Inuzuka, Pengda Liu, Shoreh Varmeh, et al. “SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.” Molecular Cell 59, no. 6 (September 2015): 917–30. https://doi.org/10.1016/j.molcel.2015.07.026.
    Full Text
  - Scafoglio, Claudio, Bruce A. Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A. Moatamed, et al. “Functional expression of sodium-glucose transporters in cancer.” Proceedings of the National Academy of Sciences 112, no. 30 (July 28, 2015): E4111–19. https://doi.org/10.1073/pnas.1511698112.
    Full Text
  - Tsao, Che-kai, Kathryn P. Gray, Mari Nakabayashi, Carolyn Evan, Philip W. Kantoff, Jiaoti Huang, Matthew D. Galsky, Mark Pomerantz, and William K. Oh. “Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease.” Journal of Urology 194, no. 1 (July 2015): 91–97. https://doi.org/10.1016/j.juro.2015.01.078.
    Full Text
  - Peek, Elizabeth M., Wang Song, Hanwei Zhang, Jiaoti Huang, and Arnold I. Chin. “Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.” The Prostate 75, no. 5 (April 2015): 463–73. https://doi.org/10.1002/pros.22932.
    Full Text
  - Escamilla, J., S. Schokrpur, C. Liu, S. J. Priceman, D. Moughon, Z. Jiang, F. Pouliot, et al. “CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy.” Cancer Research 75, no. 6 (March 15, 2015): 950–62. https://doi.org/10.1158/0008-5472.can-14-0992.
    Full Text
  - Le, Jesse D., Nelly Tan, Eugene Shkolyar, David Y. Lu, Lorna Kwan, Leonard S. Marks, Jiaoti Huang, Daniel J. A. Margolis, Steven S. Raman, and Robert E. Reiter. “Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology.” European Urology 67, no. 3 (March 2015): 569–76. https://doi.org/10.1016/j.eururo.2014.08.079.
    Full Text
  - Li, Zhen, Yin Sun, Xufeng Chen, Jill Squires, Behdokht Nowroozizadeh, Chaozhao Liang, and Jiaoti Huang. “p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.” Molecular Cancer Research 13, no. 3 (March 2015): 584–91. https://doi.org/10.1158/1541-7786.mcr-14-0277-t.
    Full Text
  - Chen, Zhong, Xun Lan, Jennifer M. Thomas‐Ahner, Dayong Wu, Xiangtao Liu, Zhenqing Ye, Liguo Wang, et al. “Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.” The Embo Journal 34, no. 4 (February 12, 2015): 502–16. https://doi.org/10.15252/embj.201490306.
    Full Text
  - Chang, Y. S., W. Y. Chen, J. J. Yin, H. Tillman, J. Huang, and Y. N. Liu. “EGF receptor promotes prostate cancer bone metastasis by downregulating miR-1 and activating TWIST1.” Cancer Research 75, no. 15 (2015): 3077–86.
    Link to Item
  - Felker, E. R., J. Wu, S. Natarajan, D. J. Margolis, S. S. Raman, J. Huang, F. Dorey, and L. S. Marks. “Serial MRI in Active Surveillance of Prostate Cancer: Incremental Value.” The Journal of Urology 195, no. 5 (2015): 1421–27.
    Link to Item
  - Gong, Y., U. D. Chippada-Venkata, M. D. Galsky, J. Huang, and M. K. Oh. “Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.” Prostate 75, no. 6 (2015): 616–27.
    Link to Item
  - Spradling, K., C. Khoyilar, G. Abedi, Z. Okhumov, J. Wikenheiser, R. Yoon, J. Huang, R. F. Youssef, G. Ghoniem, and J. Landman. “Redefining the Autonomic Nerve Distribution of the Urinary Bladder Using Three-Dimensional Image Reconstruction.” Journal of Urology 194, no. 6 (2015): 1661–67.
  - Tan, N., D. J. Margolis, D. Y. Lu, K. G. King, J. Huang, R. E. Reiter, and S. S. Raman. “Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.” Ajr. American Journal of Roentgenology 205, no. 1 (2015): W87–92.
    Link to Item
  - Wang, Denong, Jin Tang, Shaoyi Liu, and Jiaoti Huang. “Carbohydrate Microarrays Identify Blood Group Precursor Cryptic Epitopes as Potential Immunological Targets of Breast Cancer.” Journal of Immunology Research 2015 (2015): 1–9. https://doi.org/10.1155/2015/510810.
    Full Text
  - Sonn, Geoffrey A., Christopher P. Filson, Edward Chang, Shyam Natarajan, Daniel J. Margolis, Malu Macairan, Patricia Lieu, et al. “Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.” Urologic Oncology: Seminars and Original Investigations 32, no. 7 (October 2014): 952–57. https://doi.org/10.1016/j.urolonc.2014.04.003.
    Full Text
  - Hu, Jim C., Edward Chang, Shyam Natarajan, Daniel J. Margolis, Malu Macairan, Patricia Lieu, Jiaoti Huang, Geoffrey Sonn, Frederick J. Dorey, and Leonard S. Marks. “Targeted Prostate Biopsy to Select Men for Active Surveillance: Do the Epstein Criteria Still Apply?” Journal of Urology 192, no. 2 (August 2014): 385–90. https://doi.org/10.1016/j.juro.2014.02.005.
    Full Text
  - Siu, Man Kit, Wassim Abou-Kheir, Juan Juan Yin, Yung-Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, et al. “Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.” Oncotarget 5, no. 11 (June 15, 2014): 3770–84. https://doi.org/10.18632/oncotarget.1994.
    Full Text Link to Item
  - Beltran, H., S. Tomlins, A. Aparicio, V. Arora, D. Rickman, G. Ayala, J. Huang, et al. “Aggressive Variants of Castration-Resistant Prostate Cancer.” Clinical Cancer Research 20, no. 11 (June 1, 2014): 2846–50. https://doi.org/10.1158/1078-0432.ccr-13-3309.
    Full Text
  - Lusch, Achim, Ryan Leary, Emon Heidari, Michael A. Liss, Zhamshid Okhunov, Alberto Perez-Lanzac De Lorca, Jiaoti Huang, Jamie Wikenheiser, and Jaime Landman. “Intrarenal and Extrarenal Autonomic Nervous System Redefined.” Journal of Urology 191, no. 4 (April 2014): 1060–65. https://doi.org/10.1016/j.juro.2013.11.108.
    Full Text
  - Sonn, Geoffrey A., Edward Chang, Shyam Natarajan, Daniel J. Margolis, Malu Macairan, Patricia Lieu, Jiaoti Huang, Frederick J. Dorey, Robert E. Reiter, and Leonard S. Marks. “Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen.” European Urology 65, no. 4 (April 2014): 809–15. https://doi.org/10.1016/j.eururo.2013.03.025.
    Full Text
  - Sun, Feng, He-ge Chen, Wei Li, Xi Yang, Xin Wang, Richeng Jiang, Zhiyong Guo, et al. “Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors.” Journal of Biological Chemistry 289, no. 3 (January 17, 2014): 1529–39. https://doi.org/10.1074/jbc.m113.492140.
    Full Text
  - Chamie, K., G. A. Soon, D. S. Finley, N. Tan, D. J. Margolis, S. S. Raman, S. Natarajan, J. Huang, and R. E. Reiter. “RE. The role of magnetic resonance imaging in delineating clinically significant prostate cancer.” Urology 83, no. 2 (2014): 369–75.
  - Chen, Yuhchyau, Irena Nowak, Jiaoti Huang, Peter C. Keng, Hongliang Sun, Haodong Xu, Gang Wei, and Soo Ok Lee. “Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small-Cell Lung Cancer.” Journal of Thoracic Oncology 9, no. 1 (January 2014): 50–58. https://doi.org/10.1097/jto.0000000000000034.
    Full Text
  - Chin, ArnoldI, Jiaoti Huang, and Jin-Guo Wang. “RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques.” Asian Journal of Andrology 16, no. 5 (2014): 715–715. https://doi.org/10.4103/1008-682x.129942.
    Full Text
  - Drake, J. M., and J. Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proceedings of the National Academy of Sciences of Usa 111, no. 35 (2014): 12578–79.
    Link to Item
  - Drake, J. M., and J. Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proceedings of the National Academy of Sciences of Usa, 2014.
  - Huang, Jiaoti, Julia Lipianskaya, Alexa Cohen, Elaine Hsia, Jill Squires, Zhen Li, Yaqun Zhang, et al. “Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.” Asian Journal of Andrology 16, no. 4 (2014): 541–541. https://doi.org/10.4103/1008-682x.123669.
    Full Text
  - Huang, Jiaoti, Xiang Xu, and Julia Lipianskaya. “Fasting times in serum PSA assay.” Asian Journal of Andrology 16, no. 5 (2014): 786–786. https://doi.org/10.4103/1008-682x.125405.
    Full Text
  - Kroeger, N., D. B. Seligson, S. Signoretti, H. Yu, C. E. Magyar, J. Huang, A. S. Beldegrum, and A. J. Pantuck. “Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α.” European Journal of Cancer 50, no. 8 (2014): 1531–40.
  - Le, J. D., J. Huang, and L. S. Marks. “Targeted prostate biopsy: Value of multi-parametric magnetic resonance imaging in detection of localized cancer.” Asian Journal of Andrology 16, no. 4 (2014): 522–29.
    Link to Item
  - Le, J. D., S. Stephenson, M. Brugger, D. Y. Lu, P. Lieu, G. A. Sonn, S. Natarajan, et al. “Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.” Journal of Urology 192, no. 5 (2014): 1367–73.
  - Priester, A., S. Natarajan, J. D. Le, J. Garritano, B. Radosavcev, W. Grundfest, D. J. A. Margolis, L. S. Marks, and J. Huang. “A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.” American Journal of Clinical and Experimental Urology 2 (2014): 127–35.
  - Wang, L., S. R. Williamson, S. Zhang, J. Huang, R. Montironi, D. D. Davison, M. Wang, et al. “Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.” Molecular Carcinogenesis 54, no. 9 (2014): 900–907.
  - Stoyanova, Tanya, Aaron R. Cooper, Justin M. Drake, Xian Liu, Andrew J. Armstrong, Kenneth J. Pienta, Hong Zhang, et al. “Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.” Proc Natl Acad Sci U S A 110, no. 50 (December 10, 2013): 20111–16. https://doi.org/10.1073/pnas.1320565110.
    Full Text Link to Item
  - Lu, Yi-Tsung, Libo Zhao, Qinglin Shen, Mitch A. Garcia, Dongxia Wu, Shuang Hou, Min Song, et al. “NanoVelcro Chip for CTC enumeration in prostate cancer patients.” Methods 64, no. 2 (December 2013): 144–52. https://doi.org/10.1016/j.ymeth.2013.06.019.
    Full Text
  - Srigley, J. R., B. Delahunt, J. N. Eble, L. Egevad, J. I. Epstein, D. Grignon, O. Hes, et al. “The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.” The American Journal of Surgical Pathology 37, no. 10 (October 2013): 1469–89. https://doi.org/10.1097/PAS.0b013e318299f2d1.
    Full Text
  - Ren, Shancheng, Fubo Wang, Jian Shen, Yi Sun, Weidong Xu, Ji Lu, Min Wei, et al. “Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.” European Journal of Cancer 49, no. 13 (September 2013): 2949–59. https://doi.org/10.1016/j.ejca.2013.04.026.
    Full Text
  - Seiler, Daniel, Junying Zheng, Gentao Liu, Shunyou Wang, Joyce Yamashiro, Robert E. Reiter, Jiaoti Huang, and Gang Zeng. “Enrichment of putative prostate cancer stem cells after androgen deprivation: Upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.” The Prostate 73, no. 13 (September 2013): 1378–90. https://doi.org/10.1002/pros.22685.
    Full Text
  - Zong, Yang, Andrew S. Goldstein, and JiaoTi Huang. “The molecular basis for ethnic variation and histological subtype differences in prostate cancer.” Science China Life Sciences 56, no. 9 (September 2013): 780–87. https://doi.org/10.1007/s11427-013-4522-0.
    Full Text
  - Finley, David S., Daniel Margolis, Steve S. Raman, Benjamin M. Ellingson, Shyam Natarajan, Nelly Tan, Jiaoti Huang, and Robert E. Reiter. “Fine-tuning robot-assisted radical prostatectomy planning with MRI.” Urologic Oncology: Seminars and Original Investigations 31, no. 6 (August 2013): 766–75. https://doi.org/10.1016/j.urolonc.2011.07.013.
    Full Text
  - Ittmann, M., J. Huang, E. Radaelli, P. Martin, S. Signoretti, R. Sullivan, B. W. Simons, et al. “Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee.” Cancer Research 73, no. 9 (May 1, 2013): 2718–36. https://doi.org/10.1158/0008-5472.can-12-4213.
    Full Text
  - Li, Zhen, Clark J. Chen, Jason K. Wang, Elaine Hsia, Wei Li, Jill Squires, Yin Sun, and Jiaoti Huang. “Neuroendocrine differentiation of prostate cancer.” Asian Journal of Andrology 15, no. 3 (May 2013): 328–32. https://doi.org/10.1038/aja.2013.7.
    Full Text
  - An, J., H. Liu, C. E. Magyar, Y. Guo, M. S. Veena, E. S. Srivatsan, J. Huang, and M. B. Rettig. “Hyperactivated JNK Is a Therapeutic Target in pVHL-Deficient Renal Cell Carcinoma.” Cancer Research 73, no. 4 (February 15, 2013): 1374–85. https://doi.org/10.1158/0008-5472.can-12-2362.
    Full Text
  - Chen, R., X. Zeng, R. Zhang, J. Huang, X. Kuang, J. Yang, J. Liu, O. Tawfik, J. Brantly Thrasher, and B. Li. “Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers.” Urologic Oncology: Seminars and Original Investigations 32, no. 5 (2013): 524–36.
  - Cheng, L., X. Wang, X. Teng, J. Huang, and Y. Na. “Recent development in the staging of bladder urothelial carcinoma.” Chinese Journal of Urology 34 (2013): 328–32.
  - Delahunt, B., J. C. Cheville, G. Martignoni, P. A. Humphrey, C. Magi-Galluzzi, J. McKenney, L. Egevad, et al. “The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.” American Journal of Surgical Pathology 37, no. 10 (January 1, 2013): 1490–1504. https://doi.org/10.1097/PAS.0b013e318299f0fb.
    Full Text
  - Drake, J. M., N. A. Graham, J. K. Lee, T. Stoyanova, C. M. Faltermeier, S. Sud, B. Titz, et al. “Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.” Proceedings of the National Academy of Sciences of Usa, no. 110.49 (2013): E4762-4769.
  - Gollapudi, Kiran, Colette Galet, Tristan Grogan, Hong Zhang, Jonathan W. Said, Jiaoti Huang, David Elashoff, Stephen J. Freedland, Matthew Rettig, and William J. Aronson. “Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy.” Am J Cancer Res 3, no. 5 (2013): 523–29.
    Link to Item
  - Huang, J., J. K. Wang, and Y. Sun. “Molecular Pathology of Prostate Cancer Revealed by Next Generation Sequencing: Opportunities for Genome-Based Personalized Therapy.” Current Opinion in Urology 23 (2013): 189–93.
  - Huang, J., P. H. Tan, L. Cheng, N. Rioux-Leclercq, M. J. Merino, G. Netto, V. E. Reuter, et al. “Renal tumors: diagnostic and prognostic biomarkers.” American Journal of Surgical Pathology 37 (2013): 1518–31.
  - Ren, S., Y. Liu, W. Xu, Y. Sun, J. Lu, F. Wang, M. Wei, et al. “Long Noncoding RNA MALAT-1 is a New Potential Therapeutic Target for Castration-Resistant Prostate Cancer.” Journal of Urology 190, no. 6 (2013): 2278–87.
  - Schelling, L. A., S. R. Williamson, S. Zhang, J. L. Yao, M. Wang, J. Huang, R. Montironi, et al. “Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of FISH over ERG immunohistochemistry.” Human Pathology 44 (2013): 2227–33.
  - Sonn, Geoffrey A., Shyam Natarajan, Daniel J. A. Margolis, Malu MacAiran, Patricia Lieu, Jiaoti Huang, Frederick J. Dorey, and Leonard S. Marks. “Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion Device.” Journal of Urology 189, no. 1 (January 2013): 86–92. https://doi.org/10.1016/j.juro.2012.08.095.
    Full Text
  - Stoyanova, T., A. R. Cooper, J. M. Drake, X. Liu, A. J. Armstrong, K. J. Pienta, H. Zhang, et al. “Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells.” Proceedings of the National Academy of Sciences of Usa, no. 110 (2013): 20111–16.
  - Paik, Daniel Y., Deanna M. Janzen, Amanda M. Schafenacker, Victor S. Velasco, May S. Shung, Donghui Cheng, Jiaoti Huang, Owen N. Witte, and Sanaz Memarzadeh. “Stem-Like Epithelial Cells Are Concentrated in the Distal End of the Fallopian Tube: A Site for Injury and Serous Cancer Initiation.” Stem Cells 30, no. 11 (November 2012): 2487–97. https://doi.org/10.1002/stem.1207.
    Full Text
  - Liu, Nan, Sheng Tai, Boxiao Ding, Ryan K. Thor, Sunita Bhuta, Yin Sun, and Jiaoti Huang. “Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis.” Endocrine Related Cancer 19, no. 5 (October 2012): 711–23. https://doi.org/10.1530/erc-12-0150.
    Full Text
  - Tan, Nelly, Daniel J. A. Margolis, Timothy D. McClure, Albert Thomas, David S. Finley, Robert E. Reiter, Jiaoti Huang, and Steven S. Raman. “Radical prostatectomy: value of prostate MRI in surgical planning.” Abdominal Imaging 37, no. 4 (August 2012): 664–74. https://doi.org/10.1007/s00261-011-9805-y.
    Full Text
  - Chen, Hongbing, Yin Sun, Chengyu Wu, Clara E. Magyar, Xinmin Li, Liang Cheng, Jorge L. Yao, et al. “Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway.” Endocrine Related Cancer 19, no. 3 (June 2012): 321–31. https://doi.org/10.1530/erc-11-0368.
    Full Text
  - Tai, Sheng, Yin Sun, Nan Liu, Boxiao Ding, Elaine Hsia, Sunita Bhuta, Ryan K. Thor, Robert Damoiseaux, Chaozhao Liang, and Jiaoti Huang. “Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells.” Molecular Cancer Therapeutics 11, no. 6 (June 2012): 1320–31. https://doi.org/10.1158/1535-7163.mct-11-0954.
    Full Text
  - Qin, Jichao, Xin Liu, Brian Laffin, Xin Chen, Grace Choy, Collene R. Jeter, Tammy Calhoun-Davis, et al. “The PSA−/lo Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration.” Cell Stem Cell 10, no. 5 (May 2012): 556–69. https://doi.org/10.1016/j.stem.2012.03.009.
    Full Text
  - Ding, Boxiao, Yin Sun, and Jiaoti Huang. “Overexpression of SKI Oncoprotein Leads to p53 Degradation through Regulation of MDM2 Protein Sumoylation.” Journal of Biological Chemistry 287, no. 18 (April 27, 2012): 14621–30. https://doi.org/10.1074/jbc.m111.301523.
    Full Text
  - Mulholland, D. J., N. Kobayashi, M. Ruscetti, A. Zhi, L. M. Tran, J. Huang, M. Gleave, and H. Wu. “Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells.” Cancer Research 72, no. 7 (April 1, 2012): 1878–89. https://doi.org/10.1158/0008-5472.can-11-3132.
    Full Text
  - Drake, J. M., N. A. Graham, T. Stoyanova, A. Sedghi, A. S. Goldstein, H. Cai, D. A. Smith, et al. “Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression.” Proceedings of the National Academy of Sciences of Usa, no. 109 (2012): 1643–48.
  - Stoyanova, T., A. S. Goldstein, H. Cai, J. M. Drake, J. Huang, and O. N. Witte. “Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling.” Genes & Development 26 (2012): 2271–85.
  - Zong, Y., J. Huang, D. Sankarasharma, T. Morikawa, M. Fukayama, J. I. Epstein, K. K. Chada, and O. N. Witte. “Stromal epigenetic dysregulation is sufficient to initiate mouse prostate cancer via paracrine Wnt signaling.” Proceedings of the National Academy of Sciences of Usa, no. 109 (2012): E3395–3404.
  - Tai, Sheng, Yin Sun, Jill M. Squires, Hong Zhang, William K. Oh, Chao-Zhao Liang, and Jiaoti Huang. “PC3 is a cell line characteristic of prostatic small cell carcinoma.” The Prostate 71, no. 15 (November 2011): 1668–79. https://doi.org/10.1002/pros.21383.
    Full Text
  - Mulholland, David J., Linh M. Tran, Yunfeng Li, Houjian Cai, Ashkan Morim, Shunyou Wang, Seema Plaisier, et al. “Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth.” Cancer Cell 19, no. 6 (June 2011): 792–804. https://doi.org/10.1016/j.ccr.2011.05.006.
    Full Text
  - Natarajan, Shyam, Leonard S. Marks, Daniel J. A. Margolis, Jiaoti Huang, Maria Luz Macairan, Patricia Lieu, and Aaron Fenster. “Clinical application of a 3D ultrasound-guided prostate biopsy system.” Urologic Oncology: Seminars and Original Investigations 29, no. 3 (May 2011): 334–42. https://doi.org/10.1016/j.urolonc.2011.02.014.
    Full Text
  - Cheng, Liang, Shaobo Zhang, Riley Alexander, Yongxue Yao, Gregory T. MacLennan, Chong-xian Pan, Jiaoti Huang, Mingsheng Wang, Rodolfo Montironi, and Antonio Lopez-Beltran. “The landscape ofEGFRpathways and personalized management of non-small-cell lung cancer.” Future Oncology 7, no. 4 (April 2011): 519–41. https://doi.org/10.2217/fon.11.25.
    Full Text
  - Wang, Shutao, Kan Liu, Jian Liu, Zeta T-F Yu, Xiaowen Xu, Libo Zhao, Tom Lee, et al. “Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers.” Angewandte Chemie International Edition 50, no. 13 (March 21, 2011): 3084–88. https://doi.org/10.1002/anie.201005853.
    Full Text
  - Cai, H., I. Babic, X. Wei, J. Huang, and O. N. Witte. “Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy.” Cancer Research 71, no. 3 (February 1, 2011): 862–72. https://doi.org/10.1158/0008-5472.can-10-1605.
    Full Text
  - Berney, D. M., T. M. Wheeler, D. J. Grignon, J. I. Epstein, D. F. Griffiths, P. A. Humphrey, T. van der Kwast, et al. “Working group 4: seminal vesicles and lymph nodes.” Modern Pathology, no. 24 (2011): 39–47.
  - Cheng, L., S. Zhang, J. Huang, N. Li, and Y. Na. “A critical evaluation of the current histological grading system for non-invasive papillary urothelial carcinoma.” Chinese Journal of Urology 32 (2011): 427–31.
  - Findeis-Hosey, J. J., J. Huang, F. Li, Q. Yang, L. A. McMahon, and H. Xu. “High Grade Neuroendocrine Carcinomas of the Lung Highly Express EZH2 but Carcinoids Do Not.” Human Pathology 42 (2011): 867–72.
  - Goldstein, A. S., J. M. Drake, D. L. Burnes, D. S. Finley, H. Zhang, R. E. Reiter, J. Huang, and O. N. Witte. “Methods for the purification and direct transformation of epithelial progenitor cells from primary human prostate.” Nature Protocols 6 (2011): 656–67.
  - Goldstein, A. S., and J. Huang. “Do neuroendocrine cells come up large in small cell lung cancer?” Cell Cycle 10 (2011): 3627–3627.
  - Kohli, M., K. Williams, J. L. Yao, R. A. Dennis, J. Huang, J. Reeder, and W. A. Ricke. “Thrombin Expression in Prostate: A Novel Finding.” Cancer Investigation 29 (2011): 62–67.
  - Kwast, T. H. van der, M. B. Amin, A. Billis, J. I. Epstein, D. Griffiths, P. A. Humphrey, R. Montironi, et al. “Working group 2: T2 substaging and prostate cancer volume.” Modern Pathology, no. 24 (2011): 16–25.
  - Magi-Galluzzi, C., A. J. Evans, B. Delahunt, J. I. Epstein, D. F. Griffiths, T. H. van der Kwasr, R. Montironi, et al. “Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease.” Modern Pathology, no. 24 (2011): 26–38.
  - Memarzadeh, S., H. Cai, D. M. Janzen, L. Xin, R. Likacs, M. Riedinger, Y. Zong, et al. “Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.” Proceedings of the National Academy of Sciences of Usa, no. 108 (2011): 7962–67.
  - Schauer, I. G., J. Zhang, I. Mercado-Uribe, M. T. Deavers, J. Huang, and J. Liu. “The oncogenic gene fusion TMPRSS2: ERG is not a diagnostic or prognostic marker for ovarian cancer.” International Journal of Clinical And. Experimental Pathology 4 (2011): 644–50.
  - Sun, Y., J. Perera, B. P. Rubin, and J. Huang. “SYT-SSX1 (Synovial Sarcoma Translocated) regulates PIASy to cause overexpression of NCOA3.” The Journal of Biological Chemistry 286 (2011): 18623–32.
  - Sun, Yin, and Jiao-Ti Huang. “Novel genetic loci associated with prostate cancer in the Japanese population.” Asian Journal of Andrology 13, no. 1 (January 2011): 120–21. https://doi.org/10.1038/aja.2010.118.
    Full Text
  - Tan, P. H., L. Cheng, J. R. Srigley, D. Griffiths, P. A. Humphrey, T. H. van der Kwast, R. Montironi, et al. “Working group 5: surgical margins.” Modern Pathology, no. 24 (2011): 48–57.
  - Williamson, S. R., S. Zhang, J. L. Yao, J. Huang, A. Lopez-Beltran, S. Shen, A. O. Osunkoya, G. T. MacLennan, R. Montironi, and L. Cheng. “ERG-TMPRSS2 Rearrangement is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Further Evidence Supporting Monoclonal Origin.” Modern Pathology 24 (2011): 1120–27.
  - Wang, J., R. F. Place, V. Huang, X. Wang, E. J. Noonan, C. E. Magyar, J. Huang, and L. -. C. Li. “Prognostic Value and Function of KLF4 in Prostate Cancer: RNAa and Vector-Mediated Overexpression Identify KLF4 as an Inhibitor of Tumor Cell Growth and Migration.” Cancer Research 70, no. 24 (December 15, 2010): 10182–91. https://doi.org/10.1158/0008-5472.can-10-2414.
    Full Text
  - Fang, Fang, Whitney V. Christian, Sadie G. Gorman, Mei Cui, Jiaoti Huang, Kim Tieu, and Nazzareno Ballatori. “Neurosteroid transport by the organic solute transporter OSTα-OSTβ.” Journal of Neurochemistry 115, no. 1 (October 2010): 220–33. https://doi.org/10.1111/j.1471-4159.2010.06920.x.
    Full Text
  - Shen, Pengfei, Wuran Wei, Xiaochun Yang, Hao Zeng, Xiong Li, Jie Yang, Jia Wang, and Jiaoti Huang. “The influence of percutaneous nephrolithotomy on human systemic stress response, SIRS and renal function.” Urological Research 38, no. 5 (October 2010): 403–8. https://doi.org/10.1007/s00240-010-0259-4.
    Full Text
  - Ward, Stephen C., Jiaoti Huang, Satish K. Tickoo, Swan N. Thung, Marc Ladanyi, and David S. Klimstra. “Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.” Modern Pathology 23, no. 9 (September 2010): 1180–90. https://doi.org/10.1038/modpathol.2010.105.
    Full Text
  - Yang, G., D. G. Rosen, G. Liu, F. Yang, X. Guo, X. Xiao, F. Xue, et al. “CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis.” Clinical Cancer Research 16, no. 15 (August 1, 2010): 3875–86. https://doi.org/10.1158/1078-0432.ccr-10-0483.
    Full Text
  - Goldstein, A. S., J. Huang, C. Guo, I. P. Garraway, and O. N. Witte. “Identification of a Cell of Origin for Human Prostate Cancer.” Science 329, no. 5991 (July 30, 2010): 568–71. https://doi.org/10.1126/science.1189992.
    Full Text
  - Marks, Leonard S., and Jiaoti Huang. “Re: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.” European Urology 57, no. 4 (April 2010): 727–28. https://doi.org/10.1016/j.eururo.2010.01.028.
    Full Text
  - Huang, Jiaoti, and Owen N. Witte. “A Seminal Finding for Prostate Cancer?” New England Journal of Medicine 362, no. 2 (January 14, 2010): 175–76. https://doi.org/10.1056/nejmcibr0909965.
    Full Text
  - Lawson, D. A., Z. Zong, S. Memarzadeh, L. Xin, J. Huang, and O. N. Witte. “Basal epithelial stem cells are efficient targets for prostate cancer initiation.” Proceedings of the National Academy of Sciences of Usa 107 (2010): 2610–15.
  - Memarzadeh, S., Y. Zong, D. M. Janzen, A. S. Goldstein, D. Cheng, T. Kurita, A. M. Schafenacker, J. Huang, and O. N. Witte. “Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.” Proceedings of the National Academy of Sciences of Usa, no. 107 (2010): 17298–303.
  - Silvers, C. R., K. Williams, L. Salamone, J. Huang, C. T. Jordan, H. Zhou, and G. S. Palapattu. “A novel in vitro assay of human prostate cancer tumor initiation.” Prostate 70 (2010): 1379–87.
  - Tanaka, H., E. Kono, C. P. Tran, H. Miyazaki, J. Yamashiro, T. Shimomura, F. Ladan, et al. “Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, invasion, metastasis and castration resistance.” Nature Medicine 16 (2010): 1414–20.
  - Palapattu, Ganesh S., Chengyu Wu, Christopher R. Silvers, Heather B. Martin, Karin Williams, Linda Salamone, Timothy Bushnell, Li-Shan Huang, Qi Yang, and Jiaoti Huang. “Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.” The Prostate 69, no. 7 (May 15, 2009): 787–98. https://doi.org/10.1002/pros.20928.
    Full Text
  - Simon, Rochelle A., P Anthony di Sant’Agnese, Li-Shan Huang, Haodong Xu, Jorge L. Yao, Qi Yang, Sharon Liang, et al. “CD44 expression is a feature of prostatic small cell Carcinoma and Distinguishes it from its Mimickers.” Human Pathology 40, no. 2 (February 2009): 252–58. https://doi.org/10.1016/j.humpath.2008.07.014.
    Full Text
  - Huang, J., P. Lee, Y. Mikami, and J. Melamed. “Dysplastic ("in-situ") Lesions in multifocal renal oncocytomas (oncocytosis).” International Journal of Clinical And. Experimental Pathology 2 (2009): 583–87.
  - Sun, Y., J. Niu, and J. Huang. “Neuroendocrine differentiation in prostate cancer.” American Journal of Translational Research 1 (2009): 148–62.
  - Deng, X., H. Liu, J. Huang, L. Cheng, E. T. Keller, S. J. Parsons, and C. -. D. Hu. “Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression.” Cancer Research 68, no. 23 (December 1, 2008): 9663–70. https://doi.org/10.1158/0008-5472.can-08-2229.
    Full Text
  - Li, Lin, Haodong Xu, Betsy O. Spaulding, Liang Cheng, Rochelle Simon, Jorge L. Yao, P Anthony di Sant’Agnese, Patricia A. Bourne, and Jiaoti Huang. “Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors.” Human Pathology 39, no. 8 (August 2008): 1205–11. https://doi.org/10.1016/j.humpath.2007.12.012.
    Full Text
  - Gobbo, Stefano, John N. Eble, Jiaoti Huang, David J. Grignon, Mingsheng Wang, Guido Martignoni, Matteo Brunelli, and Liang Cheng. “Schwannoma of the Kidney.” Modern Pathology 21, no. 6 (June 2008): 779–83. https://doi.org/10.1038/modpathol.2008.52.
    Full Text
  - Yao, Jorge L., Jiaoti Huang, and P. Anthony di Sant’Agnese. “Small cell carcinoma of the prostate.” Diagnostic Histopathology 14, no. 3 (March 2008): 117–21. https://doi.org/10.1016/j.mpdhp.2008.02.005.
    Full Text
  - Cai, Y., Y. -. F. Lee, G. Li, S. Liu, B. -. Y. Bao, J. Huang, C. L. Hsu, and C. Chang. “A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor.” International Jouranl of Cancer 123 (2008): 195–201.
  - Johnson, A. M., M. J. O’Connell, H. Miyamoto, J. Huang, J. L. Yao, E. M. Messing, and J. E. Reeder. “Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.” Bmc Urology 8, no. 7 (2008).
  - Lei, J. L., and J. Huang. “Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma.” Expert Opinion on Medical Diagnostics 2 (2008): 151–59.
  - Li, L., J. L. Yao, P. A. di Sant’ Agnese, P. A. Bourne, M. M. Picken, A. N. Young, S. S. Shen, and J. Huang. “Expression of Claudin-7 in Benign Kidney and Kidney Tumors.” International Journal of Clinical And. Experimental Pathology 1 (2008): 57–64.
  - Liu, B., H. -. M. I. Yu, J. Huang, and W. Hsu. “Co-opted Jnk/Sapk signaling in Wnt/b-catenin-induced tumorigenesis.” Neoplasia 10 (2008): 1004–13.
  - Ross, R. W., T. M. Beer, S. Jacobus, G. T. Bubley, M. -. E. Taplin, C. Ryan, J. Huang, and W. K. Oh. “A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel.” Cancer 112 (2008): 521–26.
  - Ross, R. W., T. M. Beer, S. Jacobus, G. T. Bubley, M. -. E. Taplin, C. Ryan, J. Huang, and W. K. Oh. “A Phase II study of carboplatin plus docetaxel in men with metastatic hormone refractory prostate cancer who are refractory to docetaxel.” Cancer 112 (2008): 521–26.
  - Simon, R. A., P. A. di Sant’ Agnese, G. S. Palapattu, ea Singer, gd Candelario, J. Huang, and J. L. Yao. “Mucinous Tubular and Spindle Cell Carcinoma of the Kidney with Sarcomatoid Differentiation.” International Journal for Computer Assisted Radiology and Surgery 1 (2008): 180–84.
  - Hui, Pei, Hanlin L. Wang, Peiguo Chu, Bin Yang, Jiaoti Huang, Rebecca N. Baergen, Jeffrey Sklar, Ximing J. Yang, and Robert A. Soslow. “Absence of Y chromosome in human placental site trophoblastic tumor.” Modern Pathology 20, no. 10 (October 2007): 1055–60. https://doi.org/10.1038/modpathol.3800941.
    Full Text
  - Oh, William K., Miah-Hiang Tay, and Jiaoti Huang. “Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?” Cancer 109, no. 3 (February 1, 2007): 477–86. https://doi.org/10.1002/cncr.22439.
    Full Text
  - Bhatt, S., J. Huang, and V. S. Dogra. “Littoral cell angioma of spleen: Radiologic-pathologic correlation.” Ajr. American Journal of Roentgenology 188, no. 5 (2007): 1365–66.
  - Cheng, L., S. Zhang, M. Wang, D. D. Davidson, M. J. Morton, J. Huang, S. Zheng, T. D. Jones, S. D. Beck, and R. S. Foster. “Molecular Genetic Evidence Supporting the Neoplastic Nature of Stromal Cells in “Fibrosis” After Chemotherapy for Testicular Germ Cell Tumors.” American Journal of Pathology 213 (2007): 65–71.
  - Huang, J., C. Wu, P. A. di Sant’Agnese, J. L. Yao, L. Cheng, and Y. Na. “Function and molecular mechanisms of neuroendocrine cells in prostate cancer.” Analytical and Quantitative Cytology and Histology / the International Academy of Cytology [And] American Society of Cytology 29 (2007): 128–38.
  - Huang, J., J. J. Liang, Z. Wang, L. Chiriboga, M. A. Greco, E. Shapiro, H. Huang, et al. “The expression and function of androgen receptor coactivator p44 and protein arginine methyltransfersase 5 (PRMT5) in the developing testis and testicular tumors.” Journal of Urology 177, no. 5 (2007): 1918–22.
  - Podder, T. K., J. Sherman, L. Li, J. Joseph, D. R. Rubens, E. M. Messing, J. Huang, and Y. Yu. “Mechanical properties of human prostate tissue in the context of surgical needle insertion.” International Journal for Computer Assisted Radiology and Surgery 2, no. Suppl I (2007): S106–8.
  - Wagner, D. G., J. L. Yao, P. A. di Sant’Agnese, L. Cheng, A. Lopez-Beltran, R. Montironi, and J. Huang. “Soft tissue tumors in the prostate.” Analytical and Quantitative Cytology and Histology / the International Academy of Cytology [And] American Society of Cytology 29 (2007): 341–50.
  - Wagner, David, Jean Joseph, Jiaoti Huang, and Haodong Xu. “Malakoplakia of the Prostate on Needle Core Biopsy: A Case Report and Review of the Literature.” International Journal of Surgical Pathology 15, no. 1 (January 2007): 86–89. https://doi.org/10.1177/1066896906295892.
    Full Text
  - Wu, C., and J. Huang. “PI3 kinase-AKT-mTOR pathway is involved in neuroendocrine differentiation of prostate cancer.” The Journal of Biological Chemistry 282, no. 6 (2007): 3571–83.
  - Huang, Jiaoti, Jorge L. Yao, P Anthony di Sant’Agnese, Qi Yang, Patricia A. Bourne, and Yanqun Na. “Immunohistochemical characterization of neuroendocrine cells in prostate cancer.” The Prostate 66, no. 13 (September 15, 2006): 1399–1406. https://doi.org/10.1002/pros.20434.
    Full Text
  - Johnson, Aimee M., David L. Conover, Jiaoti Huang, Edward M. Messing, Ruola Ning, Mary J. O’Connell, M Adrian Rossi, et al. “Early detection and measurement of urothelial tumors in mice.” Urology 67, no. 6 (June 2006): 1309–14. https://doi.org/10.1016/j.urology.2005.12.011.
    Full Text
  - Yao, Jorge L., Ralph Madeb, Patricia Bourne, Junyi Lei, Ximing Yang, Satish Tickoo, Zhengzhi Liu, et al. “Small Cell Carcinoma of the Prostate: An Immunohistochemical Study.” The American Journal of Surgical Pathology 30, no. 6 (June 2006): 705–12. https://doi.org/10.1097/00000478-200606000-00005.
    Full Text
  - Lei, J., P. A. Bourne, P. A. di Sant’Agnese, and J. Huang. “Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma versus cholangiocarcinoma and metastatic carcinoma of the liver.” American Journal of Clinical Pathology 125 (2006): 519–25.
  - Markhardt, K. B., D. J. Rubens, J. Huang, and V. S. Dogra. “Sonographic features of Biliary Hamartomas with histopathological correlation.” Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine 25 (2006): 1631–33.
  - Sun, Y., D. Gao, Y. Liu, J. Huang, S. Lessnick, and S. Tanaka. “IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SX1.” Oncogene 25 (2006): 1042–52.
  - Wu, C., J. L. Yao, P. A. Di Sant’Agnese, Y. Na, and J. Huang. “Neuroendocrine differentiation in prostate cancer.” Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology 35 (2006): 565–67.
  - Wu, C., L. Zhang, P. A. Bourne, J. E. Reeder, P. A. di Sant’Agnese, J. L. Yao, Y. Nia, and J. Huang. “Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cance.” Prostate 66 (2006): 1125–35.
  - Zang, Z., D. G. Rosen, J. L. Yao, J. Huang, and J. Liu. “Expression of p14(ARF), p15(INK4b), p16(INK4a), and DCR2 increases during prostate cancer progression.” Modern Pathology 19 (2006): 1339–43.
  - Li, Huixiang, Lurong Zhang, Hong Lou, Ivan Ding, Sunghee Kim, Luping Wang, Jiaoti Huang, P Anthony Di Sant’Agnese, and Jun-Yi Lei. “Overexpression of Decoy Receptor 3 in Precancerous Lesions and Adenocarcinoma of the Esophagus.” American Journal of Clinical Pathology 124, no. 2 (August 2005): 282–87. https://doi.org/10.1309/xk594e4b5wu82qr6.
    Full Text
  - Li, Rongshan, Jing Ni, Patricia A. Bourne, Shuyuan Yeh, Jorge Yao, P Anthony di Sant’Agnese, and Jiaoti Huang. “Cell Culture Block Array for Immunocytochemical Study of Protein Expression in Cultured Cells.” Applied Immunohistochemistry & Molecular Morphology 13, no. 1 (March 2005): 85–90. https://doi.org/10.1097/00129039-200503000-00014.
    Full Text
  - Huang, J., C. Wu, J. L. Yao, and P. A. di Sant’Agnese. “Neuroendocrine differentiation in prostate cancer.” Edited by B. Q. Wu. Proceedings of the 4th Asian Pacific International Academy of Pathology Congress, 2005, 57–61.
  - Huang, J., J. L. Yao, L. Zhang, P. A. Bourne, A. M. Quinn, P. A. di Sant’Agnese, and J. E. Reeder. “Differential expression of Interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer.” American Journal of Pathology 166 (2005): 1807–15.
  - Hu, Yueh-Chiang, Shuyuan Yeh, Shauh-Der Yeh, Erik R. Sampson, Jiaoti Huang, Peng Li, Cheng-Lung Hsu, et al. “Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer.” Journal of Biological Chemistry 279, no. 32 (August 6, 2004): 33438–46. https://doi.org/10.1074/jbc.m401781200.
    Full Text
  - Patton, Kurt T., Maria S. Tretiakova, Jorge L. Yao, Veronica Papavero, Lei Huo, Brian P. Adley, Guan Wu, et al. “Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.” The American Journal of Surgical Pathology 28, no. 8 (August 2004): 1045–50. https://doi.org/10.1097/01.pas.0000128661.58697.7d.
    Full Text
  - Li, R., J. L. Yao, P. A. Bourne, P. A. di Sant’agnese, and J. Huang. “Frequent expression of human carcinoma-associated antigen (HCA), a mucin-type glycoprotein, by cells of prostatic carcinom.” Archives of Pathology & Laboratory Medicine 128 (2004): 1412–17.
  - Liang, S., J. L. Yao, P. A. Bourne, P. A. di Sant’Agnese, J. Huang, and J. Lei. “Over-Expression of Human Carcinoma-Associated Antigen in Esophageal Adenocarcinoma and its Precursor Lesions.” American Journal of Clinical Pathology 122 (2004): 747–51.
  - Yao, J. L., P. A. Bourne, Q. Yang, P. A. di Sant’Agnese, and J. Huang. “Overexpression of Human Carcinoma-Associated Antigen (HCA) in Urothelial Carcinoma of the Bladder.” Archives of Pathology & Laboratory Medicine 128 (2004): 785–87.
  - Chen, Terina S., Melanie McNally, William Hulbert, P Anthony di Sant’Agnese, and Jiaoti Huang. “Renal Oncocytosis Presenting in Childhood: A Case Report.” International Journal of Surgical Pathology 11, no. 4 (October 2003): 325–29. https://doi.org/10.1177/106689690301100415.
    Full Text
  - Ni, Jing, Ming Chen, Yu Zhang, Rongshan Li, Jiaoti Huang, and Shuyuan Yeh. “Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.” Biochem Biophys Res Commun 300, no. 2 (January 10, 2003): 357–63. https://doi.org/10.1016/s0006-291x(02)02851-6.
    Full Text Link to Item
  - Daiss, J., J. Carney, R. Cartun, J. Codington, C. Erdrich, C. Hinchman, J. Huang, J. Mauck, and P. Schnipelsky. “Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer.” Journal of Clinical Ligand Assay 26 (2003): 177–80.
  - Huang, J., C. Behrens, I. I. Wistuba, A. F. Gazdar, and J. Jagirdar. “Clonality of combined tumors: A molecular genetic study.” Archives of Pathology & Laboratory Medicine 126 (2002): 437–41.
  - Lee, Y. -. F., W. -. J. Lin, J. Huang, E. M. Messing, F. L. Chan, G. Wilding, and C. Chang. “Activation of Mitogen-activated Protein Kinase Pathway by the Antiandrogen Hydroxyflutamide in Androgen Receptor-negative Prostate Cancer Cells.” Cancer Research 62 (2002): 6039–42.
  - Liu, Z., J. Huang, Z. Yan, and J. Tan. “Application of flow cytometry in the diagnosis and differential disgnosis of lymphoma and leukemia.” Zhonghua Bing Li Xue Za Zhi Chinese Journal of Pathology 31 (2002): 352–53.
  - Huang, Jiaoti, Carmen Behrens, Ignacio Wistuba, Adi F. Gazdar, and Jaishree Jagirdar. “Molecular analysis of synchronous and metachronous tumors of the lung: Impact on management and prognosis.” Annals of Diagnostic Pathology 5, no. 6 (December 2001): 321–29. https://doi.org/10.1053/adpa.2001.29338.
    Full Text
  - Gu, Mai, Weiji Shi, Jiaoti Huang, Richard R. Barakat, Howard T. Thaler, and Patricia E. Saigo. “Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma.” Cancer 90, no. 3 (June 25, 2000): 143–47. https://doi.org/10.1002/1097-0142(20000625)90:3<143::aid-cncr2>3.0.co;2-h.
    Full Text
  - SARIC, M. U. H. A. M. E. D., ROBERT M. APPLEBAUM, ALFRED T. CULLIFORD, J. I. A. O. T. I. HUANG, JOHN V. SCHOLES, and I. T. Z. H. A. K. KRONZON. “Massive Atrial Septal Lipomatous Hypertrophy.” Echocardiography 16, no. 8 (November 1999): 833–34. https://doi.org/10.1111/j.1540-8175.1999.tb00137.x.
    Full Text
  - Huang, J., M. Mohammadi, G. A. Rodrigues, and J. Schlessinger. “Reduced activation of RAF-1 and MAP kinase by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositol hydrolysis.” The Journal of Biological Chemistry 270 (1995): 5065–72.
  - Trachman, J. D., J. Huang, and G. H. Reem. “Activation of human thymocytes induces the phosphorylation of protein tyrosine phosphatase IC.” Comptes Rendus De L’Académie Des Sciences Paris De La Vie/Life Sciences 318 (1995): 367–74.
  - Spivak-Kroizman, T., M. A. Lemmon, I. Dikic, J. E. Ladbury, D. Pinchasi, J. Huang, M. Jaye, G. Crumley, J. Schlessinger, and I. Lax. “Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.” Cell 79, no. 6 (December 1994): 1015–24. https://doi.org/10.1016/0092-8674(94)90032-9.
    Full Text
  - Huang, J. “Internalization of fibroblast growth factor receptor is inhibited by a point mutation at tyrosine 766.” The Journal of Biological Chemistry 269 (1994): 17056–61.
  - Vogel, W., R. Lammers, J. Huang, and A. Ullrich. “Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.” Science 259, no. 5101 (March 12, 1993): 1611–14. https://doi.org/10.1126/science.7681217.
    Full Text
  - Levy, J. B., P. D. Canoll, O. Silvennoinen, G. Barnea, B. Morse, A. M. Honegger, J. Huang, et al. “The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system.” The Journal of Biological Chemistry 268 (1993): 10573–81.
  - Huang, Jiaoti, and Robert J. Schneider. “Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein.” Cell 65, no. 2 (April 1991): 271–80. https://doi.org/10.1016/0092-8674(91)90161-q.
    Full Text
  - Dolph, P. J., J. Huang, and R. J. Schneider. “Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.” Journal of Virology 64 (1990): 2669–77.
  - Huang, J., and R. J. Schneider. “Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine.” Proceedings of the National Academy of Sciences of the United States of America 87, no. 18 (1990): 7115–19.
  - Huang, J., and Z. Tang. “Measurement of estrogen receptor in the nuclei of bone marrow cells of male mice after the administration of estrogen.” Bulletin of the Academy of Military Medical Sciences 2 (1988): 24–26.
  - Acharya, U., A. Adare, C. Aidala, N. N. Ajitanand, Y. Akiba, R. Akimoto, M. Alfred, et al. “Measurement of charged pion double spin asymmetries at midrapidity in longitudinally polarized p+p collisions at s=510 GeV.” Physical Review D 102, no. 3 (n.d.). https://doi.org/10.1103/physrevd.102.032001.
    Full Text
  - Guo, Shengjie, Feng Sun, Zhiyong Guo, Wei Li, Alan Alfano, Hegang Chen, Clara E. Magyar, et al. “Tyrosine Kinase ETK/BMX Is Up-Regulated in Bladder Cancer and Predicts Poor Prognosis in Patients with Cystectomy.” Plos One 6, no. 3 (n.d.): e17778–e17778. https://doi.org/10.1371/journal.pone.0017778.
    Full Text
  - Hu, Chang-Deng, Richard Choo, and Jiaoti Huang. “Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure.” Frontiers in Oncology 5 (n.d.). https://doi.org/10.3389/fonc.2015.00090.
    Full Text
  - Liss, Michael A., Nathan S. White, J Kellogg Parsons, Natalie M. Schenker-Ahmed, Rebecca Rakow-Penner, Joshua M. Kuperman, Hauke Bartsch, et al. “MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.” Frontiers in Oncology 5 (n.d.). https://doi.org/10.3389/fonc.2015.00030.
    Full Text
  - Xu, Lingfan, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Juan Liu, James Beasley, et al. “A Glutaminase Isoform Switch Drives Therapeutic Resistance and Disease Progression of Prostate Cancer,” n.d.
  - Yuan, Ping, Humam Kadara, Carmen Behrens, Ximing Tang, Denise Woods, Luisa M. Solis, Jiaoti Huang, et al. “Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung.” Plos One 5, no. 2 (n.d.): e9112–e9112. https://doi.org/10.1371/journal.pone.0009112.
    Full Text
- Book Sections
  - Koo, J., C. P. Filson, J. Huang, and A. J. Pantuck. “Collecting Duct Carcinoma and Renal Medullary Carcinoma.” In The Kidney: A Comprehensive Guide to Pathologic Diagnosis and Management, edited by D. E. Hansel, C. J. Kane, G. P. Paner, and S. Chang, 109–23, 2016.
  - Brick, A., J. Niu, J. Huang, and W. K. Oh. “Possibility for Platinum Chemotherapy Treatment for HRPC Patients?” In Drug Management of Prostate Cancer, edited by W. D. Figg, C. H. Chau, and E. J. Small, 153–61. NJ: Humana Press, 2010.
  - Wu, C., G. Chen, Y. Na, D. Xin, J. L. Yao, P. A. di Xant’ Agnese, and J. Huang. “The function of Interleukin-8 in prostate cancer.” In Progress in Chemokine Research, edited by W. P. Links, 149–56. New York: Nova Science Publishers, 2007.
  - Huang, J., J. L. Yao, and P. A. di Sant’Agnese. “Neuroendocrine Differentiation in Prostate Cancer.” In Prostate Cancer: Principles and Practice, edited by R. Kirby, A. W. Partin, M. Feneley, and J. K. Parsons, 143–50. London, UK: Martin Dunitz Ltd (Taylor & Francis Group), 2005.
  - Huang, J., and P. A. di Sant’ Agnese. “Neuroendocrine Differentiation in Prostate Cancer: An Overview.” In Advances in Oncology: The Expanding Role of Octreotide I, edited by S. W. J. Lamberts and L. Dogliotti, 243–62. Bristol, UK: BioScientifica Ltd, 2002.
- Digital Publications
  - Wagner, D. G., and J. Huang. “Small Cell Carcinoma of the Prostate.” eMedicine from WebMD, April 20, 2009.
    Link to Item
- Conference Papers
  - Kwon, Daniel, Li Zhang, Adam Foye, William S. Chen, Felix Y. Feng, Adina Bailey, Jiaoti Huang, et al. “ADRB2 expression in progressive metastatic castration-resistant prostate cancer.” In Journal of Clinical Oncology, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.
    Link to Item
  - Morris, D. C., D. Y. Chan, H. Chen, M. L. Palmeri, T. J. Polascik, W. C. Foo, J. Huang, J. Mamou, and K. R. Nightingale. “Multiparametric Ultrasound for the Targeting of Prostate Cancer using ARFI, SWEI, B-mode, and QUS.” In Ieee International Ultrasonics Symposium, Ius, 2019-October:880–83, 2019. https://doi.org/10.1109/ULTSYM.2019.8926035.
    Full Text
  - Gholap, Abhi, Anagha P. Jadhav, Suraj Somwanshi, Gurunath Kamble, Isha Doshi, and Jiaoti Huang. “Abstract 1149: Systems pathology by Optra 30 color multiplex immunofluorescence automated whole slide imaging system integrated with image analysis.” In Tumor Biology. American Association for Cancer Research, 2019. https://doi.org/10.1158/1538-7445.am2019-1149.
    Full Text
  - Labriola, Matthew, Jason Zhu, Sachica Cheris, Xin Liu, Kathryn Perkinson, Zuowei Su, Shannon McCall, et al. “Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).” In Journal of Clinical Oncology, 37:e14259–e14259. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.15_suppl.e14259.
    Full Text
  - Romero, Gustavo Rubio, Alana Weinstein, Verena Friedl, Adam Foye, Denise Playdle, Alexis Sabol, Patricia Li, et al. “Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).” In Journal of Clinical Oncology, Vol. 37. AMER SOC CLINICAL ONCOLOGY, 2019.
    Link to Item
  - Zhu, Jason, Matthew Labriola, Sachica Cheris, Xin Liu, Kathryn Perkinson, Zuowei Su, Shannon McCall, et al. “Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).” In Journal of Clinical Oncology, 37:577–577. American Society of Clinical Oncology (ASCO), 2019. https://doi.org/10.1200/jco.2019.37.7_suppl.577.
    Full Text
  - Liu, Yen-Nien, Wei-Yu Chen, Yuan-Chin Tsai, Hsiu-Lien Yeh, Florent Suau, and Jiaoti Huang. “Abstract A031: Androgen deprivation therapy-induced TGFBI signaling promotes EMT and bone metastasis of prostate cancer.” In Poster Presentations Proffered Abstracts. American Association for Cancer Research, 2018. https://doi.org/10.1158/1538-7445.prca2017-a031.
    Full Text
  - Hsu, En-chi, Meghan Rice, Rosalie Nolley, Abel Bermudez, Jiaoti Huang, Donna Peehl, Christian Kunder, Sharon Pitteri, James Brooks, and Tanya Stoyanova. “Defining new drivers of castration- resistant prostate cancer.” In Cancer Research, 78:90–90. AMER ASSOC CANCER RESEARCH, 2018.
    Link to Item
  - Taylor, Clive, Anagha P. Jadhav, Abhi Gholap, Gurunath Kamble, Jiaoti Huang, Allen Gown, Isha Doshi, and David Rimm. “Abstract 1695: A multi-institutional study to evaluate automated scoring of immunohistochemistry slides for assessment of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.” In Immunology. American Association for Cancer Research, 2018. https://doi.org/10.1158/1538-7445.am2018-1695.
    Full Text
  - Aggarwal, Rahul Raj, Paul Lloyd, Jiaoti Huang, Tomasz M. Beer, Li Zhang, George V. Thomas, Lawrence D. True, et al. “DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.” In Journal of Clinical Oncology, 36:5039–5039. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5039.
    Full Text
  - Aggarwal, Rahul Raj, Li Zhang, Tomasz M. Beer, Jack Youngren, Alise Stromlund, Alexander Bell, Adam Foye, et al. “Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.” In Journal of Clinical Oncology, 36:278–278. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.6_suppl.278.
    Full Text
  - Kim, Won, Eric Jay Small, Rahul Raj Aggarwal, Robert Benjamin Den, Jonathan Lehrer, Li Zhang, Jack Youngren, et al. “Luminal and basal subtyping of metastatic castration-resistant prostate cancer (mCRPC) and its clinical implications.” In Journal of Clinical Oncology, 36:197–197. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.6_suppl.197.
    Full Text
  - Huang, Jiaoti, Yu Yin, George Thomas, Lawrence True, Tomasz M. Beer, Martin Gleeve, Owen Witte, et al. “Histologic Spetrum of Metastatic Castration-Resistant Prostate Cancer.” In Laboratory Investigation, 97:231A-231A. NATURE PUBLISHING GROUP, 2017.
    Link to Item
  - Huang, Jiaoti, Yu Yin, George Thomas, Lawrence True, Tomasz M. Beer, Martin Gleeve, Owen Witte, et al. “Histologic Spetrum of Metastatic Castration-Resistant Prostate Cancer.” In Modern Pathology, 30:231A-231A. NATURE PUBLISHING GROUP, 2017.
    Link to Item
  - Small, Eric Jay, Rahul Raj Aggarwal, Jiaoti Huang, Artem Sokolov, Li Zhang, Joshi J. Alumkal, Jack Youngren, et al. “Clinical and genomic characterization of metastatic small cell/neuroendocrine prostate cancer (SCNC) and intermediate atypical prostate cancer (IAC): Results from the SU2C/PCF/AACRWest Coast Prostate Cancer Dream Team (WCDT).” In Journal of Clinical Oncology, 34:5019–5019. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.5019.
    Full Text
  - Asvadi, Nazanin, Pooria Khoshnoodi, Hector Alcala, Amin Moshksar, Daniel Margolis, Anthony Sisk, Jiaoti Huang, Robert Reiter, and Steven Raman. “MP21-16 3T MULTI-PARAMETRIC MRI PERFORMANCE IN PROSTATE CANCER DETECTION: PERIPHERAL ZONE TUMORS VS. TRANSITIONAL ZONE.” In Journal of Urology, Vol. 195. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.1016/j.juro.2016.02.650.
    Full Text
  - Natarajan, Shyam, Steven Raman, Alan Priester, James Garritano, Daniel Margolis, Patricia Lieu, Maria Macairan, Jiaoti Huang, Warren Grundfest, and Leonard Marks. “MP18-11 MR-GUIDED FOCAL LASER ABLATION OF INTERMEDIATE RISK PROSTATE CANCER: PHASE I TRIAL.” In Journal of Urology, Vol. 195. Ovid Technologies (Wolters Kluwer Health), 2016. https://doi.org/10.1016/j.juro.2016.02.2712.
    Full Text
  - Margolis, Daniel, Nelly Tan, Shyam Natarajan, Karim Chamie, David Finley, Robert Evan Reiter, Jiaoti Huang, and Steven Raman. “Value of prostate MRI in determining appropriate candidates for active surveillance.” In Journal of Clinical Oncology, 30:109–109. American Society of Clinical Oncology (ASCO), 2012. https://doi.org/10.1200/jco.2012.30.5_suppl.109.
    Full Text
  - Samaratunga, H., R. Montrironi, L. True, J. I. Epstein, D. F. Griffiths, P. A. Humphrey, T. van der Kwast, et al. “Working group 1: specimen handling.” In Modern Pathology, 6–15. Nature Publishing Group, 2011.
  - Samaratunga, H., R. Montrironi, L. True, J. I. Epstein, D. F. Griffiths, P. A. Humphrey, T. van der Kwast, et al. “Working group 1: specimen handling.” In Modern Pathology, 6–15. Nature Publishing Group, 2011.
Teaching & Mentoring
Recent Courses

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Selected Grants

External Relationships

Selected Publications

Academic Articles

Book Sections

Digital Publications

Conference Papers

Recent Courses